Compile Data Set for Download or QSAR
Report error Found 1690 Enz. Inhib. hit(s) with Target = 'Protein O-GlcNAcase'
TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM139926(US8901087, 2)
Affinity DataKi:  0.0500nM ΔG°:  -58.8kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions are carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acety...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/4/2015
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM481715(US10913733, Example 26)
Affinity DataKi:  0.0750nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM481707(N-(5-((4-(4-(N,N- dimethylsulfamoyl) benzylidene)p...)
Affinity DataKi:  0.0950nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM77064(US9695197, 4)
Affinity DataKi:  0.110nM ΔG°:  -56.8kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM481720(US10913733, Example 31)
Affinity DataKi:  0.117nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM139933(US8901087, 27)
Affinity DataKi:  0.120nM ΔG°:  -56.6kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions are carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acety...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/4/2015
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM177755(US9120781, 18)
Affinity DataKi:  0.130nM ΔG°:  -56.4kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions are carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acety...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2016
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM179374(US9126957, 10)
Affinity DataKi:  0.140nM ΔG°:  -56.2kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions are carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acety...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM139959(US8901087, 191)
Affinity DataKi:  0.140nM ΔG°:  -56.2kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions are carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acety...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/4/2015
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM139951(US8901087, 95)
Affinity DataKi:  0.160nM ΔG°:  -55.9kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions are carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acety...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/4/2015
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM314813((3aR,5S,6S,7R,7aR)-5-((R)-1-(4- benzylbenzyloxy)-2...)
Affinity DataKi:  0.160nMAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2019
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM481715(US10913733, Example 26)
Affinity DataKi:  0.167nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM139952(US8901087, 97)
Affinity DataKi:  0.170nM ΔG°:  -55.8kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions are carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acety...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/4/2015
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM139925(US8901087, 1)
Affinity DataKi:  0.170nM ΔG°:  -55.8kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions are carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acety...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/4/2015
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM139946(US8901087, 76)
Affinity DataKi:  0.180nM ΔG°:  -55.6kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions are carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acety...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/4/2015
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM314809((3aR,5S,6S,7R,7aR)-2-(dimethylamino)-5-((R)-1-meth...)
Affinity DataKi:  0.190nMAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/30/2019
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM46008(US8901087, 96)
Affinity DataKi:  0.190nM ΔG°:  -55.5kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions are carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acety...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/4/2015
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM177758(US9120781, 26)
Affinity DataKi:  0.200nM ΔG°:  -55.4kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions are carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acety...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/25/2016
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM458383(1-(2-(((3R,5S)-1-((6-fluoro-2-methylbenzo[d]thiazo...)
Affinity DataIC50: 0.214nMAssay Description:The OGA enzyme catalyses the removal of O-GlcNAc from nucleocytoplasmic proteins. To measure this activity Fluorescein di-N-acetyl-β-N-acetyl-D-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM458383(1-(2-(((3R,5S)-1-((6-fluoro-2-methylbenzo[d]thiazo...)
Affinity DataIC50: 0.214nMAssay Description:The OGA enzyme catalyses the removal of O-GlcNAc from nucleocytoplasmic proteins. To measure this activity Fluorescein di-N-acetyl-β-N-acetyl-D-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM458383(1-(2-(((3R,5S)-1-((6-fluoro-2-methylbenzo[d]thiazo...)
Affinity DataIC50: 0.214nMAssay Description:Inhibition of full-length human N-terminal poly-His tagged OGA expressed in baculovirus infected Sf9 cells using FD-GlcNAc as substrate preincubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM139941(US8901087, 63)
Affinity DataKi:  0.220nM ΔG°:  -55.1kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions are carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acety...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/4/2015
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM481739(US10913733, Example 50)
Affinity DataKi:  0.241nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM179370(US9126957, 6)
Affinity DataKi:  0.260nM ΔG°:  -54.7kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions are carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acety...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM179366(US9126957, 2)
Affinity DataKi:  0.260nM ΔG°:  -54.7kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions are carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acety...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/9/2016
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM481711(N-(5-((4-((1-oxoisoindolin- 5-yl)methylene)piperid...)
Affinity DataKi:  0.268nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM481727((S,Z)-N-(5-((4-(4- methoxybenzylidene)-2- methylpi...)
Affinity DataKi:  0.287nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM481698(4-((1-((2-acetamidothiazol- 5-yl)methyl)-piperidin...)
Affinity DataKi:  0.294nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM240645(US9409924, (3aR,5R,6R,7S,7aR)-2-(dimethylamino)-7-...)
Affinity DataKi:  0.300nM ΔG°:  -54.4kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2017
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM205418(US9243020, (3aR,5R,6S,7R,7aR)-2-(ethylamino)-5-(hy...)
Affinity DataKi:  0.300nM ΔG°:  -54.4kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM240657(US9409924, 34)
Affinity DataKi:  0.300nM ΔG°:  -54.4kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2017
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM205418(US9243020, (3aR,5R,6S,7R,7aR)-2-(ethylamino)-5-(hy...)
Affinity DataKi:  0.300nMAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM139930(US8901087, 11)
Affinity DataKi:  0.300nM ΔG°:  -54.4kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions are carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acety...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/4/2015
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM481718(US10913733, Example 29)
Affinity DataKi:  0.324nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM139939(US8901087, 57)
Affinity DataKi:  0.330nM ΔG°:  -54.1kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions are carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acety...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/4/2015
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50646035(CHEMBL5591488)
Affinity DataIC50: 0.340nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
10/12/2025
Entry Details
PubMed
TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50513934(CHEMBL4443587)
Affinity DataKi:  0.360nMAssay Description:Inhibition of recombinant human OGAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM458387(1-[2-[(3R,5S)-1-[(1S)-1-(6-fluoro-2-methyl-1,3-ben...)
Affinity DataIC50: 0.385nMAssay Description:The OGA enzyme catalyses the removal of O-GlcNAc from nucleocytoplasmic proteins. To measure this activity Fluorescein di-N-acetyl-β-N-acetyl-D-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/30/2021
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM458387(1-[2-[(3R,5S)-1-[(1S)-1-(6-fluoro-2-methyl-1,3-ben...)
Affinity DataIC50: 0.385nMAssay Description:Inhibition of full-length human N-terminal poly-His tagged OGA expressed in baculovirus infected Sf9 cells using FD-GlcNAc as substrate preincubated ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM458387(1-[2-[(3R,5S)-1-[(1S)-1-(6-fluoro-2-methyl-1,3-ben...)
Affinity DataIC50: 0.385nMAssay Description:The OGA enzyme catalyses the removal of O-GlcNAc from nucleocytoplasmic proteins. To measure this activity Fluorescein di-N-acetyl-β-N-acetyl-D-...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/11/2021
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM481697(N-(5-((4-((1H-pyrazol-4- yl)methylene)piperidin-1-...)
Affinity DataKi:  0.387nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM481741(US10913733, Example 54 | US10913733, Example 52)
Affinity DataKi:  0.389nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM481600(US10913733, Example 1)
Affinity DataKi:  0.392nMAssay Description:Experimental procedure for kinetic analyses: Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (p...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2021
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50323697(thiamet-G | (3AR,5R,6S,7R,7AR)-2-(ETHYLAMINO)-5-(H...)
Affinity DataKi:  0.400nM ΔG°:  -53.6kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/12/2016
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM240644(US9409924, (3aR,5R,6R,7S,7aR)-2-(ethylamino)-7-flu...)
Affinity DataKi:  0.400nM ΔG°:  -53.6kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
7/31/2017
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50323697(thiamet-G | (3AR,5R,6S,7R,7AR)-2-(ETHYLAMINO)-5-(H...)
Affinity DataKi:  0.400nM ΔG°:  -53.6kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/6/2018
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM139931(US8901087, 13)
Affinity DataKi:  0.400nM ΔG°:  -53.6kJ/molepH: 7.0 T: 2°CAssay Description:Enzymatic reactions are carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acety...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/4/2015
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50323697(thiamet-G | (3AR,5R,6S,7R,7AR)-2-(ETHYLAMINO)-5-(H...)
Affinity DataKi:  0.400nMAssay Description:Enzymatic reactions were carried out in a reaction containing 50 mM NaH2PO4, 100 mM NaCl and 0.1% BSA (pH 7.0) using 2 mM 4-Methylumbelliferyl N-acet...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/14/2019
Entry Details
Go to US Patent

TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50323697(thiamet-G | (3AR,5R,6S,7R,7AR)-2-(ETHYLAMINO)-5-(H...)
Affinity DataIC50: 0.410nMAssay Description:Inhibition of human O-GlcNAcaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2021
Entry Details Article
PubMed
TargetProtein O-GlcNAcase(Human)
Merck Sharp & Dohme

US Patent
LigandPNGBDBM50323697(thiamet-G | (3AR,5R,6S,7R,7AR)-2-(ETHYLAMINO)-5-(H...)
Affinity DataKi:  0.410nMAssay Description:Inhibition of recombinant human OGAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/21/2021
Entry Details Article
PubMed
Displayed 1 to 50 (of 1690 total ) | Next | Last >>
Jump to: